title: Drug-related problems identified in post-discharge medication reviews for patients taking warfarin.
abstract: OBJECTIVE
  To characterise the nature of the drug-related problems with warfarin therapy identified in pharmacist-conducted medication reviews during a collaborative post-discharge warfarin management service, with a focus on potentially serious drug interactions.
  
  
  METHODS
  Australian community pharmacy practice.
  
  
  METHODS
  Medication review reports submitted by pharmacists to patients' general practitioners as part of the service were reviewed and the type and clinical significance of the warfarin-associated drug-related problems, and the pharmacists' recommendations were classified. The prevalence of prescribing of 'potentially hazardous' warfarin drug interactions was investigated and compared with the frequency of documentation of these interactions in the medication review reports.
  
  
  METHODS
  The number and nature of warfarin-associated drug-related problems identified and the rate of documentation of 'potentially hazardous' warfarin drug interactions in the reports from pharmacist-conducted medication reviews.
  
  
  RESULTS
  A total of 157 warfarin-associated drug-related problems were documented in 109 medication review reports (mean 1.4 per patient, 95% CI 1.3-1.6, range 0-5). Drug selection and Education or information were the most commonly identified warfarin-associated drug-related problems; most drug-related problems were of moderate clinical significance. Eight of 23 potentially serious warfarin drug interactions (34.8%) were identified in the medication review reports.
  
  
  CONCLUSIONS
  Pharmacists addressing drug selection and warfarin education drug-related problems during medication reviews may have contributed to the positive outcomes of the post-discharge service. Warfarin drug interactions were frequently identified; however, well-recognised potentially hazardous interactions were under-reported. Improved communication along the continuum of care would permit improved targeting of drug-related problem reporting, especially in relation to preventable drug interactions.
authors: Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Private Bag 26, Hobart Tasmania 7001, Australia. leannes2@utas.edu.au
authors: Leanne
authors: L
authors: Stafford
authors: Andrew
authors: A
authors: Stafford
authors: Josephine
authors: J
authors: Hughes
authors: Manya
authors: M
authors: Angley
authors: Luke
authors: L
authors: Bereznicki
authors: Gregory
authors: G
authors: Peterson
references: Ann Intern Med. 2000 Nov 7;133(9):687-95
references: 11074901
references: JAMA. 2006 Oct 18;296(15):1858-66
references: 17047216
references: J Clin Pharm Ther. 2011 Feb;36(1):27-32
references: 21108651
references: J Gen Intern Med. 2005 Apr;20(4):317-23
references: 15857487
references: J Intern Med. 2001 Oct;250(4):327-41
references: 11576320
references: Ann Pharmacother. 2011 Mar;45(3):325-34
references: 21386021
references: Clin Lab Haematol. 1988;10(1):109-12
references: 3365930
references: Thromb Haemost. 2009 Aug;102(2):268-78
references: 19652877
references: Med J Aust. 2005 Mar 21;182(6):267-70
references: 15777140
references: Thromb Res. 2009 May;124(1):37-41
references: 19062079
references: Chest. 2008 Jun;133(6 Suppl):160S-198S
references: 18574265
references: Ann Pharmacother. 2003 Jan;37(1):34-9
references: 12503930
references: Am J Med. 1991 Jun;90(6):667-74
references: 2042681
references: Arch Intern Med. 2007 Feb 12;167(3):239-45
references: 17296878
references: Ann Pharmacother. 2004 Dec;38(12):2115-21
references: 15522981
references: Br J Clin Pharmacol. 2010 Aug;70(2):252-7
references: 20653678
references: Circulation. 2008 Oct 28;118(18):1894-909
references: 18836135
references: BMJ. 2004 Jul 3;329(7456):15-9
references: 15231615
references: Ann Pharmacother. 2004 May;38(5):859-67
references: 15054145
references: Eur Heart J. 2010 Oct;31(19):2369-429
references: 20802247
references: Drug Saf. 1993 Jul;9(1):51-9
references: 8347291
references: JAMA. 1998 Apr 15;279(15):1200-5
references: 9555760
references: Pharm World Sci. 2009 Apr;31(2):216-23
references: 19242818
references: Clin Lab Haematol. 2002 Feb;24(1):43-5
references: 11843898
references: J Qual Clin Pract. 1999 Mar;19(1):19-22
references: 10096719
references: Pharm World Sci. 2010 Oct;32(5):637-42
references: 20623338